← Leaderboards
George Ben Thornton
Cassava Sciences, Inc
$618,411
Attributed
$1,855,233
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2017–20$2M$1.5M$1M$500K$0
'17
'18
'19
'20
Funding mix
By agency
NIH$1,855,233 · 2
By mechanism
R44$1,559,890 · 1
R42$295,343 · 1
Top collaborators
- Lindsay H Burns3 shared
- Hoau-Yan Wang3 shared
Most similar at Cassava Sciences, Inc
Same institution · by research overlap
- Lindsay H Burns$16,572,741
Others in their field
Other Emerging Leaders on “S Disease”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Chanza Baytop · Westat, Inc.$271,217,917
- Beth Baseler · Leidos Biomedical Research, Inc.$249,760,384
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$220,039,059
- Kimberly Smith · Ppd Development Lp$115,671,664
- Beverly Hayes · Leidos Biomedical Research, Inc.$98,336,166
Research focus
S DiseaseAlzheimer&AposDiagnosticAllelesAlpha-Bungarotoxin ReceptorDiagnosisAntibodiesBloodAntigensArchivesAutopsyBaseBindingAmyloid Beta-ProteinBlindedAffinityBrainAntibody FormationClinical DiagnosisClinical TrialsCommercializationCompanion DiagnosticsDementiaDetection
Grant awards (3)
Development of PTI-125-DX, a blood-based diagnostic for Alzheimer's disease$450,142
R44 · FY2020 · AG · contact PI
Development of PTI-125-DX, a blood-based diagnostic for Alzheimer's disease$1,109,748
R44 · FY2019 · AG · contact PI
Development of PTI-125-DX, a blood-based diagnostic for Alzheimer's disease$295,343
R42 · FY2017 · AG · contact PI